日常睡眠-清醒节律,γ-分泌酶和粉样β病理之间的相互作用表明存在复杂的潜在关系
Savannah M Turton1, Samantha Padgett1, M Tyler Maisel1
1The Sanders-Brown Center on Aging, USA.
Biochimica et biophysica acta. Molecular basis of disease
|April 13, 2025
概括
睡眠障碍加剧了阿尔茨海默氏症 (AD) 病理,特别是在雌性小鼠中. 马分泌酶抑制剂治疗降低了粉样β (Aβ) 水平,这表明在阿尔茨海默症发育中,睡眠,Aβ产生和性别之间的复杂相互作用.
科学领域:
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
- 生物化学 生物化学
背景情况:
- 睡眠障碍是阿尔茨海默病 (AD) 和相关痴呆症的已知危险因素.
- 慢性睡眠碎片化加速AD神经病理,包括粉样β (Aβ) 积累.
- 睡眠对Aβ产生的影响,而不仅仅是清除,仍然不清楚.
研究的目的:
- 在AD的小鼠模型中调查Aβ生产和睡眠功能障碍之间的复杂关系.
- 探索睡眠碎片化和g-分泌酶抑制对Aβ病理学的性别特异性影响.
主要方法:
- APP × PS1突变的敲门小鼠遭受了轻微的睡眠碎片化 (SF).
- 在SF期间,小鼠接受了g-分泌酶抑制剂 (Semagacestat®) 的治疗.
- 在不同的分数中分析了粉样蛋白前体蛋白的Aβ水平和C端片段.
主要成果:
- 与雄性相比,雌性小鼠的睡眠减少和Aβ病理增加.
- 塞马加塞斯塔特治疗降低了Aβ,主要是溶解分数,并阻断了女性的SF诱导的Aβ增加.
- 睡眠碎片化诱导了粉样蛋白前体蛋白碎片的性别依赖性变化.
结论:
- 睡眠障碍和AD病理之间的联系是复杂的,涉及与生物性别的相互作用.
- 睡眠可能会影响Aβ的产生,这种相互作用是由性别和γ-分泌酶活性调节的.
- 了解这些性别特异性机制对于解决女性观察到的较高AD风险至关重要.
更多相关视频
06:40Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
Published on: January 25, 2018
6.7K
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
5.2K
相关概念视频
Alzheimer's Disease: Overview
328
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
328
Amyloid Fibrils
9.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.1K
